Silence Therapeutics plc (SLN)

NASDAQ: SLN · Real-Time Price · USD

14.72

-0.71 (-4.60%)

At close: Aug 11, 2026, 4:00 PM EDT

14.75

+0.03 (0.20%)

After-hours: Aug 11, 2026, 7:53 PM EDT

Silence Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-	-97.81	-56.57	-54.23	-50.33	-62
Depreciation & Amortization	-	0.56	0.58	0.62	0.6	0.58
Stock-Based Compensation	-	8.22	16	16.27	12.69	11.67
Other Adjustments	-	3.36	-6.72	3.12	-0.6	8.45
Change in Receivables	-	1.04	-0.89	0.39	-0.72	37.16
Changes in Accounts Payable	-	-3.5	0.67	-0.47	2.02	3.25
Changes in Income Taxes Payable	-	-0.65	-0.43	-	-	-
Changes in Unearned Revenue	-	-0.34	-28.25	-10.32	-5.44	11.31
Changes in Other Operating Activities	-	19.65	7.66	-4.84	-15.26	-1.22
Operating Cash Flow	-	-69.46	-67.93	-49.46	-57.04	9.2
Operating Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-0	-0.06	-0.21	-0.06	-0.17	-1.77
Purchases of Intangible Assets	-	-	-	-	-0.37	-0.03
Purchases of Investments	-	-169.44	-136.58	-25.77	-19.95	-
Proceeds from Sale of Investments	-	120.63	115.23	45.12	-	13.52
Other Investing Activities	-	1.91	1.91	-	-	0.01
Investing Cash Flow	126.23	-46.95	-19.65	19.29	-20.5	11.73

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Repaid	-	-0.18	-0.22	-	-	-0.29
Net Long-Term Debt Issued (Repaid)	-	-0.18	-0.22	-	-	-0.29
Issuance of Common Stock	0	0.02	149.93	31.94	52.58	41.81
Net Common Stock Issued (Repurchased)	0	0.02	149.93	31.94	52.58	41.81
Other Financing Activities	-	-	-8.62	-	-	-
Financing Cash Flow	0	-0.16	141.08	31.94	52.58	41.52

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Foreign Exchange Rate Adjustments	-2.85	-2.32	0.14	0.75	-8.12	-0.14
Net Cash Flow	-5.6	-118.89	53.65	1.77	-24.96	62.45

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-0	-69.52	-68.14	-49.52	-57.22	7.43
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-0.72%	-12221.50%	-160.49%	-156.49%	-264.22%	44.26%
Free Cash Flow Per Share	-0.00	-1.47	-1.47	-1.33	-1.78	0.25
Levered Free Cash Flow	-20.96	-74.73	-64.42	-69.3	-68.59	-41.42
Unlevered Free Cash Flow	-69.96	-69.87	-68.07	-80.61	-80.14	-41.08

SEC Filings: 10-K · 10-Q